BioCentury
ARTICLE | Company News

Invitrogen, University of Queensland, Pamgene sales and marketing update

January 21, 2008 8:00 AM UTC

Invitrogen and PamGene will co-market Invitrogen's nuclear hormone receptor proteins and Lanthascreen assay technology with PamGene's microarray-based nuclear hormone receptor screening tools. ...